Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -193,878 | -227,102 | -263,494 | -280,321 | 127,840 |
| Depreciation Amortization | 15,615 | 16,215 | 18,007 | 17,621 | 15,406 |
| Accounts receivable | -7,661 | 9,707 | 3,935 | 4,822 | 14,118 |
| Accounts payable and accrued liabilities | -2,284 | -292 | -2,791 | 18,790 | -2,304 |
| Other Working Capital | 11,780 | 5,533 | -10,887 | 13,977 | 40,218 |
| Other Operating Activity | 52,465 | 22,814 | 36,823 | 17,623 | 23,597 |
| Operating Cash Flow | $-123,963 | $-173,125 | $-218,407 | $-207,488 | $218,875 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,454 | 105,882 | 200,903 | 18,795 | -322,467 |
| PPE Investments | -2,414 | -2,436 | -9,960 | -30,724 | -84,175 |
| Investing Cash Flow | $-15,868 | $103,446 | $190,943 | $-11,929 | $-406,642 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,366 | 133,770 | 8,221 | 4,546 | 222,487 |
| Other Financing Activity | 115,405 | -41,087 | -43,187 | -33,386 | -27,237 |
| Financing Cash Flow | $116,771 | $92,683 | $-34,966 | $-28,840 | $195,250 |
| Beginning Cash Position | 59,556 | 36,552 | 98,982 | 347,239 | 339,756 |
| End Cash Position | 36,496 | 59,556 | 36,552 | 98,982 | 347,239 |
| Net Cash Flow | $-23,060 | $23,004 | $-62,430 | $-248,257 | $7,483 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,963 | -173,125 | -218,407 | -207,488 | 218,875 |
| Capital Expenditure | -2,414 | -2,436 | -9,960 | -30,724 | -84,175 |
| Free Cash Flow | -126,377 | -175,561 | -228,367 | -238,212 | 134,700 |